Skip to main content
Proceedings of the Royal Society of Medicine logoLink to Proceedings of the Royal Society of Medicine
. 1972 Jul;65(7):584–585. doi: 10.1177/003591577206500702

Monoamines and mental disease.

M Sandler
PMCID: PMC1644220  PMID: 5085927

Full text

PDF
584

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Davis J. M. Efficacy of tranquilizing and antidepressant drugs. Arch Gen Psychiatry. 1965 Dec;13(6):552–572. doi: 10.1001/archpsyc.1965.01730060070010. [DOI] [PubMed] [Google Scholar]
  2. Hammar C. G., Holmstedt B., Lindgren J. E., Tham R. The combination of gas chromatography and mass spectrometry in the identification of drugs and metabolites. Adv Pharmacol Chemother. 1969;7:53–89. [PubMed] [Google Scholar]
  3. Morris P. A., MacKenzie D. H., Masheter H. C. A comparative double blind trial of pimozide and fluphenazine in chronic schizophrenia. Br J Psychiatry. 1970 Dec;117(541):683–684. doi: 10.1192/bjp.117.541.683. [DOI] [PubMed] [Google Scholar]
  4. Randrup A., Munkvad I. Stereotyped activities produced by amphetamine in several animal species and man. Psychopharmacologia. 1967;11(4):300–310. doi: 10.1007/BF00404607. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES